79,342 GE HealthCare Technologies Inc. $GEHC Shares Acquired by South Dakota Investment Council

South Dakota Investment Council grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 30.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 339,645 shares of the company’s stock after acquiring an additional 79,342 shares during the quarter. South Dakota Investment Council’s holdings in GE HealthCare Technologies were worth $22,203,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Ritholtz Wealth Management bought a new position in GE HealthCare Technologies during the 3rd quarter valued at about $1,285,000. Northside Capital Management LLC increased its position in GE HealthCare Technologies by 26.5% in the second quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock worth $15,485,000 after buying an additional 50,634 shares in the last quarter. TD Waterhouse Canada Inc. raised its position in shares of GE HealthCare Technologies by 5.1% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 608,890 shares of the company’s stock valued at $39,015,000 after purchasing an additional 29,752 shares during the period. Hsbc Holdings PLC grew its holdings in GE HealthCare Technologies by 22.8% during the 2nd quarter. Hsbc Holdings PLC now owns 1,004,490 shares of the company’s stock valued at $64,217,000 after buying an additional 186,800 shares in the last quarter. Finally, Trian Fund Management L.P. lifted its position in shares of GE HealthCare Technologies by 76,194.4% in the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock worth $197,493,000 after buying an additional 3,081,300 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.4%

GEHC opened at $81.84 on Wednesday. The firm’s fifty day moving average is $71.13 and its two-hundred day moving average is $70.15. The firm has a market cap of $37.00 billion, a PE ratio of 17.27, a price-to-earnings-growth ratio of 2.09 and a beta of 0.65. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.01 and a current ratio of 1.30.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The company had revenue of $5.51 billion during the quarter, compared to analyst estimates of $5.35 billion. During the same quarter in the previous year, the business earned $1.07 EPS. The firm’s revenue was up 7.2% on a year-over-year basis. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date was Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio is currently 3.38%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on GEHC. Weiss Ratings raised shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Oppenheimer restated an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Evercore restated an “outperform” rating and set a $84.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. BTIG Research raised their price target on shares of GE HealthCare Technologies from $75.00 to $83.00 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Finally, UBS Group lifted their price objective on shares of GE HealthCare Technologies from $73.00 to $80.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.17.

View Our Latest Stock Analysis on GE HealthCare Technologies

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Further Reading

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.